Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4 SUPPL., 2003, Pages

  Andersen, M Robyn ^a,b   Bowen, Deborah ^a   Yasui, Yutaka ^a   McTiernan, Anne ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Genetics; Ovarian cancer; Risk; Screening

Indexed keywords

ADULT; ARTICLE; ATTITUDE; BREAST CANCER; CANCER RISK; CANCER SCREENING; COUNSELING; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC RISK; GENETIC SCREENING; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HUMAN; NORMAL HUMAN; OVARY CANCER; PATIENT CARE; PRIORITY JOURNAL;

EID: 0242391982     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)01078-0     Document Type: Article

References (34)

1. Durfy SJ, Bowen DJ, McTiernan A, et al. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in Western Washington. Cancer Epidemiol Biomark Prevent 1999;8:369-75.
2. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 1993;28:145-55.
3. Narod SA, Feunteun J, Lenoir G, et al. Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet 1991;338:82-3.
4. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14 1996;1730-6.
5. American Cancer Society. American Cancer Society Cancer Facts and Figures - 1998. Atlanta, GA: American Cancer Society Inc, 1998.
6. Foulkes W, Glendon G, Narod S. Family history and risk of ovarian cancer. JAMA 1995;274:383.
7. Frank TS, Manley SA, Olopade OI, et al. Sequence analyses of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16:2417-25.
8. Ponder BAJ, Easton DF, Peto J. Risk of ovarian cancer associated with a family history. In: Sharp F, Leake R, editors. Ovarian Cancer. London, Chapman & Hall Ltd; 1990. p. 3-6.
9. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Lancet 1994;343:692-5.
10. Easton DF, Ford D, Bishop DT, et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Human Genet 1995;56:265-71.
11. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
12. Satagopan JM, Offit K, Foulkes W, et al. The lifetime risks of breast cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prevent 2001;10:467-73.
13. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997;277:997-1003.
14. Struewing JP, Watson P, Easton DF, et al. Prophylactic oo-phorectomy in inherited breast/ovarian cancer families. J Nat Cancer Instit Mono 1995;17:33-5.
15. Carlson K, Skate S, Singer D. Screening for ovarian cancer. Ann Intern Med 1994;121:124-32.
16. Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA125 measurement and ultrasonography. Br Med J 1993;306:1030-5.
17. Jacobs IJ, Skates S, Davies AP. Risk of diagnosis of ovarian cancer after raised serum CA-125 concentration: A prospective cohort study. Br Med J 1996;313:1355.
18. Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet 1988;336:268-71.
19. Bast RC Jr, Boyer CM, Xu FJ, et al. Molecular approaches to prevention and detection of epithelial ovarian cancer. J Cell Biochem 1995;23(suppl):219- 22.
20. Campbell S, Bhan V, Royston P, et al. Transabdominal ultrasound screening for early ovarian cancer. Br Med J 1989;299:1363-7.
21. Rosenthal A, Jacobs I. Ovarian cancer screening. Semin On col 1998;25:315-25.
22. Ovarian cancer: Screening, treatment, and follow-up. NIH Consensus Statement Apr. 5-7 1994;12:1-30.
23. Burke W, Culver JO, Bowen D, et al. Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genet 2000;90:361-8.
24. Hailey BJ. Family history of breast cancer and screening behavior: An inverted U-shaped curve? Medical Hypoth 1991;36:397-403.
25. McCaul KD, Branstetter AD, Schroeder DM, et al. What is the relationship between breast cancer risk and mamniography screening? A meta-analytic review. Health Psychol 1996;15:423-9.
26. Vogel VG, Graves DS, Vernon SW, et al. Mammographic screening of women with increased risk of breast cancer. Cancer 1990;66:1613-20.
27. Kaplan KM, Weinberg GB, Small A, et al. Breast cancer screening among relatives of women with breast cancer. Am J Public Health 1991;81:1174-8.
28. Drossaert CC, Boer H, Seydel ER, et al. Perceived risk, anxiety, mammogram uptake, and breast self-examination of women with a family history of breast cancer: The role of knowing to be at increased risk. Cancer Detect Prevent 1996;20:76-85.
29. Dresher C, Holt SK, Andersen MR, et al. Reported ovarian cancer screening among a populations based sample in Washington State. Obstet Gynecol 2000;96:70-4.
30. King ES, Rimer BK, Trock B. How valid are mammography self-reports? Am J Public Health 1990;80:1386-8.
31. McGovern PG, Lurie N, Margolis KL, et al. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prevent Med 1998;14:201-8.
32. Napier JA, Metzner H, Johnson BC. Limitations of morbidity and mortality data obtained from family histories - A report from the Tecumseh community health study. Am J Public Health 1972;62:30-5.
33. Love RR, Evans AM, Josten DM, et al. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38:289-93.
34. Bondy ML, Strom SS, Colopy MW, et al. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 1994;47:89-96.